Marwan Alrasheed

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• Medication reconciliation documentation and documented discrepancies in a tertiary Saudi hospital: a retrospective observational study
  International Journal for Quality in Health Care 2026 DOI: 10.1093/intqhc/mzag123
  +Save
• Compliance with Medications Among Saudi Pregnant Women with Diabetes: Insights from a Large Tertiary Hospital, Riyadh, Saudi Arabia
  INQUIRY: The Journal of Health Care Organization, Provision, and Financing 2026 DOI: 10.1177/00469580261420718
  +Save
• Health halo effect in supplement marketing: A content analysis of unregulated medical claims in community pharmacies
  DIGITAL HEALTH 2026 DOI: 10.1177/20552076261477561
  +Save
• Facilitators and Barriers to Prescription Medication Sharing: A Qualitative Study from the Public’s Perspective in Saudi Arabia
  Drug, Healthcare and Patient Safety 2025 DOI: 10.2147/DHPS.S553530
  +Save
• Treatment Response in Pediatric Patients with Status Epilepticus: A Retrospective Observational Study from Saudi Arabia
  Journal of Clinical Medicine 2025 DOI: 10.3390/jcm14175940
  +Save
• Therapeutic drug monitoring of vancomycin: A retrospective cross-sectional study of blood draw timing and clinical outcomes
  Medicine 2025 DOI: 10.1097/MD.0000000000042952
  +Save
• Arabic version of the patient education materials assessment tool (PEMAT): translation and validation
  Saudi Pharmaceutical Journal 2025 DOI: 10.1007/s44446-025-00013-7
  +Save
• Dalbavancin for the treatment of bone and joint infections: A meta-analysis
  Journal of Infection and Chemotherapy 2025 DOI: 10.1016/j.jiac.2024.07.013
  +Save
• Knowledge and perceptions of health literacy among pharmacists in Ohio in 2013 and 2021
  Journal of the American Pharmacists Association 2025 DOI: 10.1016/j.japh.2024.102260
  +Save
• Knowledge and Perception of Pharmacy Students toward Telepharmacy Education in Saudi Arabia
  Healthcare 2024 DOI: 10.3390/healthcare12181806
  +Save
• Privacy in Community Pharmacies in Saudi Arabia: A Cross-Sectional Study
  Healthcare 2024 DOI: 10.3390/healthcare12171740
  +Save
• Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022
  Pharmaceuticals 2024 DOI: 10.3390/ph17070815
  +Save
• Drug Expenditure, Price, and Utilization in US Medicaid: A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022
  Healthcare 2023 DOI: 10.3390/healthcare11162265
  +Save
• Association between polypharmacy, patient-reported symptoms, and quality of life among nonalcoholic fatty liver disease patients in the United States
  Drugs & Therapy Perspectives 2022 DOI: 10.1007/s40267-022-00957-z
  +Save
• The effect of polypharmacy on quality of life in adult patients with nonalcoholic fatty liver disease in the United States
  Quality of Life Research 2022 DOI: 10.1007/s11136-022-03090-6
  +Save
• Continuous quality improvement regulations for community pharmacy practice in the United States
  Journal of the American Pharmacists Association 2021 DOI: 10.1016/j.japh.2021.02.008
  +Save